60 mg tirzepatide vial 60mg/3mL (20mg/mL) Tirzepatide – 60 mg Vial

Semaglutide is one of the best-known GLP-1 medications used for chronic weight management under the brand name Wegovy

503A operations remain subject to state pharmacy board oversight and FDA compliance monitoring

doi: 10.3390/ijms21041447

Safety & Regulatory Insights GLP-1 peptide research continues to evolve, with several compounds already approved for clinical use and others in advanced trial phases: Semaglutide is FDA-approved for both type 2 diabetes (as Ozempic) and chronic weight management (as Wegovy)

Dispose of it properly and prepare a new solution if necessary

A six- to nine-day interval won't harm your treatment as much as compressing the dosing window